Cargando…

A Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects

The disaccharide and innovative ingredient cellobiose, consisting of two β-glucose molecules linked by a β(1→4) bond is the main component of cellulose. Cellobiose can be used within a wide variety of foodstuffs and functional foods as a low-caloric bulking agent or as a substitute for lactose. For...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moré, Margret Irmgard, Postrach, Elisa, Bothe, Gordana, Heinritz, Sonja, Uebelhack, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019479/ https://www.ncbi.nlm.nih.gov/pubmed/31881808 http://dx.doi.org/10.3390/nu12010064

Ejemplares similares

Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects
por: Uebelhack, Ralf, et al.
Publicado: (2019)

Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
por: Uebelhack, Ralf, et al.
Publicado: (2019)

Effects of aged garlic extract on arterial elasticity in a placebo-controlled clinical trial using EndoPAT™ technology
por: Gruenwald, Joerg, et al.
Publicado: (2020)

Safety and tolerability of escalating cannabinoid doses in healthy cats
por: Kulpa, Justyna E, et al.
Publicado: (2021)

Overcoming inefficient cellobiose fermentation by cellobiose phosphorylase in the presence of xylose
por: Chomvong, Kulika, et al.
Publicado: (2014)

Sleep Promoting Effects of IQP-AO-101: A Double-Blind, Randomized, Placebo-Controlled Exploratory Trial
por: Bongartz, Udo, et al.
Publicado: (2019)

Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in marathon race participants: A randomized, double-blind, placebo-controlled pilot study
por: Bongartz, Udo, et al.
Publicado: (2021)

Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials
por: Rasinkangas, Pia, et al.
Publicado: (2022)

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
por: Carroll, F. Ivy, et al.
Publicado: (2018)

A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
por: Gu, Kenan, et al.
Publicado: (2022)

Effects of Cactus Fiber on the Excretion of Dietary Fat in Healthy Subjects: A Double Blind, Randomized, Placebo-Controlled, Crossover Clinical Investigation
por: Uebelhack, Ralf, et al.
Publicado: (2014)

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019)

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects
por: Zhang, Hong, et al.
Publicado: (2022)

Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adults
por: Gupta, Alok K, et al.
Publicado: (2013)

Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults
por: Kavoosi, Mojgan, et al.
Publicado: (2020)

Adaptive evolution and metabolic engineering of a cellobiose- and xylose- negative Corynebacterium glutamicum that co-utilizes cellobiose and xylose
por: Lee, Jungseok, et al.
Publicado: (2016)

Simultaneous consumption of cellobiose and xylose by Bacillus coagulans to circumvent glucose repression and identification of its cellobiose-assimilating operons
por: Zheng, Zhaojuan, et al.
Publicado: (2018)

The Lipomyces starkeyi gene Ls120451 encodes a cellobiose transporter that enables cellobiose fermentation in Saccharomyces cerevisiae
por: de Ruijter, Jorg C, et al.
Publicado: (2020)

Thermoanaerobacterium thermosaccharolyticum β-glucosidase: a glucose-tolerant enzyme with high specific activity for cellobiose
por: Pei, Jianjun, et al.
Publicado: (2012)

Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
por: Vaughn, Dana, et al.
Publicado: (2020)

Polysaccharide oxidation by lytic polysaccharide monooxygenase is enhanced by engineered cellobiose dehydrogenase
por: Kracher, Daniel, et al.
Publicado: (2019)

A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
por: Laties, Alan, et al.
Publicado: (2016)

Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body’s defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects
por: Auinger, Annegret, et al.
Publicado: (2013)

Engineering of cellobiose phosphorylase for the defined synthesis of cellotriose
por: Ubiparip, Zorica, et al.
Publicado: (2020)

PHB production from cellobiose with Saccharomyces cerevisiae
por: Ylinen, Anna, et al.
Publicado: (2022)

A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects
por: Lee, Ko-Onn, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects
por: Jeon, Yoomin, et al.
Publicado: (2022)

Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
por: Groenendaal-van de Meent, Dorien, et al.
Publicado: (2018)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
por: Sheng, Lei, et al.
Publicado: (2021)

The single berberine bridge enzyme homolog of Physcomitrella patens is a cellobiose oxidase
por: Toplak, Marina, et al.
Publicado: (2018)

Interaction between Cellobiose Dehydrogenase and Lytic Polysaccharide Monooxygenase
por: Laurent, Christophe V. F. P., et al.
Publicado: (2019)

Factors Affecting the Synthesis of Cellobiose Lipids by Sporisorium scitamineum
por: Oraby, Amira, et al.
Publicado: (2020)

A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers
por: Perkins, Daniel, et al.
Publicado: (2020)

Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania
por: Kassimu, Kamaka, et al.
Publicado: (2022)

Comment on: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects”
por: Srinivas, Nuggehally R.
Publicado: (2016)

A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects
por: Leubitz, Andi, et al.
Publicado: (2021)

Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose Study
por: Kuang, Yun, et al.
Publicado: (2022)

Evaluation of Benefit and Tolerability of IQP‐CL‐101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double‐Blinded, Randomised, Placebo‐Controlled Clinical Trial
por: Alt, Felix, et al.
Publicado: (2017)

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
por: Linetsky, Eduard, et al.
Publicado: (2022)

Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
por: Liang, Beibei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5uietds5n5dsstsvieuieaduhs